<DOC>
	<DOC>NCT01952314</DOC>
	<brief_summary>This study is to investigate whether naftopidil is effective or not for the spontaneous passage of ureteral stones with sizes of 3 to 10 mm.</brief_summary>
	<brief_title>Medical Expulsive Therapy for Ureter Stone Using Naftopidil</brief_title>
	<detailed_description>1. Enrollment 1. patients with ureteral stones of sizes from 3 to 10 mm 2. patients aged more than 18 years 2. Randomization 1. naftopidil 75 mg qd for 14 days or placebo 2. Standard treatment with pain-killers were also applied.(aceclofenac) 3. Follow-up for 28 days 1. We confirm the stone free status by CT or X-ray films at 14th and 28th days. 2. Rates of active treatment will be also evaluated.</detailed_description>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>&gt;= 20 years single 3 to 10 mm ureter stone (longest diameter) Presence of multiple ureter stones Renal insufficiency (serum Cr &gt; 1.4 mg/dL) Febrile urinary tract infections(fever &gt; 38Â°C, evidence of urinary infection) pregnancy or breast feeding solitary kidney hypersensitivity to naftopidil current use of any alphablocker, calciumchannel blocker, corticosteroid (within 4 weeks) moderate or severe cardiovascular or cerebrovascular disease hepatic dysfunction (&gt;2 x normal upper limit) significant active medical illness which in the opinion of the investigator would preclude protocol treatment Genetic disorder such as Galactose intolerance, Lapp Lactase deficiency, GlucoseGalactose malabsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>